间充质干细胞——新冠病毒肺炎相关急性呼吸窘迫综合征潜在的治疗选择

• 作者: 张毅 赵璇
• 来源期刊: 工程（英文）
• 年，卷（期）: 2020,（10）
• 所属期刊栏目: Views & Comments
• 页码范围: 1073-1075,中插19-中插21
• 页数: 1页
• 语种: 英文

摘要

A recent clinical study by Chen et al. [1] reported that the trans-plantation of allogeneic menstrual-blood-derived mesenchymal stem cells (MSCs) significantly reduced the mortality of influenza A (H7N9)-virus-induced acute respiratory distress syndrome (ARDS) without harmful side effects. This work may simulta-neously provide a new insight into the treatment of ARDS caused by coronavirus disease 2019 (COVID-19).